Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sanyal

Showing results (101-110 of 686) with videos related to

Pageof 69
Sort By:
The Oncologist|December 1, 2010
The etiology of hepatocellular carcinoma and consequences for treatmentArun J Sanyal, Seung Kew Yoon, Riccardo Lencioni
Hepatology (Baltimore, Md.)|March 30, 2026
Noninvasive surrogate endpoints of adverse outcomes, disease progression, and treatment efficacy in Metabolic Dysfunction-Associated Steatohepatitis (MASH)Arun J Sanyal, Manal F Abdelmalek, Rohit Loomba
Seminars in Thrombosis and Hemostasis|June 7, 2015
Vascular Disease in Patients with Nonalcoholic Fatty Liver DiseaseWilma Potze, M Shadab Siddiqui, Arun J Sanyal
Clinics in Liver Disease|December 2, 2014
Transjugular intrahepatic portosystemic shuntKavish R Patidar, Malcolm Sydnor, Arun J Sanyal
The Gastroenterologist|March 1, 1993
Pharmacological control of gastric acid secretionA M Zfass, L McHenry, A J Sanyal
The Gastroenterologist|June 1, 1993
Nonsteroidal antiinflammatory drug-induced gastroduodenal lesions: prophylaxis and treatmentA M Zfass, L McHenry, A J Sanyal
Nature Reviews. Gastroenterology & Hepatology|October 3, 2023
Digital pathology for nonalcoholic steatohepatitis assessmentArun J Sanyal, Prakash Jha, David E Kleiner
Gastroenterology & Hepatology|June 23, 2010
The treatment of hepatic encephalopathy in the cirrhotic patientArun J Sanyal, Kevin D Mullen, Nathan M Bass
Journal of Hepatology|March 30, 2010
Use of desirability functions to evaluate health status in patients with cirrhosisChris Gennings, Douglas Heuman, Otis Fulton, et al.
Diabetes, Obesity & Metabolism|March 21, 2024
The role of glucagon-like peptide-1 receptor agonists in metabolic dysfunction-associated steatohepatitisManal F Abdelmalek, Stephen A Harrison, Arun J Sanyal
Pageof 69

Showing results (101-110 of 686) with videos related to

Sort By:
Pageof 69
The Oncologist|December 1, 2010
The etiology of hepatocellular carcinoma and consequences for treatmentArun J Sanyal, Seung Kew Yoon, Riccardo Lencioni
Hepatology (Baltimore, Md.)|March 30, 2026
Noninvasive surrogate endpoints of adverse outcomes, disease progression, and treatment efficacy in Metabolic Dysfunction-Associated Steatohepatitis (MASH)Arun J Sanyal, Manal F Abdelmalek, Rohit Loomba
Seminars in Thrombosis and Hemostasis|June 7, 2015
Vascular Disease in Patients with Nonalcoholic Fatty Liver DiseaseWilma Potze, M Shadab Siddiqui, Arun J Sanyal
Clinics in Liver Disease|December 2, 2014
Transjugular intrahepatic portosystemic shuntKavish R Patidar, Malcolm Sydnor, Arun J Sanyal
The Gastroenterologist|March 1, 1993
Pharmacological control of gastric acid secretionA M Zfass, L McHenry, A J Sanyal
The Gastroenterologist|June 1, 1993
Nonsteroidal antiinflammatory drug-induced gastroduodenal lesions: prophylaxis and treatmentA M Zfass, L McHenry, A J Sanyal
Nature Reviews. Gastroenterology & Hepatology|October 3, 2023
Digital pathology for nonalcoholic steatohepatitis assessmentArun J Sanyal, Prakash Jha, David E Kleiner
Gastroenterology & Hepatology|June 23, 2010
The treatment of hepatic encephalopathy in the cirrhotic patientArun J Sanyal, Kevin D Mullen, Nathan M Bass
Journal of Hepatology|March 30, 2010
Use of desirability functions to evaluate health status in patients with cirrhosisChris Gennings, Douglas Heuman, Otis Fulton, et al.
Diabetes, Obesity & Metabolism|March 21, 2024
The role of glucagon-like peptide-1 receptor agonists in metabolic dysfunction-associated steatohepatitisManal F Abdelmalek, Stephen A Harrison, Arun J Sanyal
Pageof 69